These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6256890)

  • 1. [Septicemia due to polyresistant Staphylococcus aureus (author's transl)].
    Bonnardot JP; Bonvoisin R; Bryskier A
    Sem Hop; 1980 Nov 18-25; 56(43-44):1850-2. PubMed ID: 6256890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vancomycin in staphylococcus septicemia (author's transl)].
    González MA; Arteaga A
    Rev Med Chil; 1974 Jul; 102(7):532-5. PubMed ID: 4471392
    [No Abstract]   [Full Text] [Related]  

  • 3. Chromatographically purified vancomycin: therapy of serious infections caused by Staphylococcus aureus and other gram-positive bacteria.
    Wang LS; Liu CY; Wang FD; Fung CP; Chiu ZH; Cheng DL
    Clin Ther; 1988; 10(5):574-84. PubMed ID: 2856600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcal sepsis in patients on chronic hemodialysis regimens: intravenous treatment with vancomycin given once weekly.
    Barcenas CG; Fuller TJ; Elms J; Cohen R; White MG
    Arch Intern Med; 1976 Oct; 136(10):1131-4. PubMed ID: 971012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of vancomycin in the treatment of severe Staphylococcus aureus infection. Description of 3 cases].
    Campelli A; Mantero E; Fabbri A; Nahum M; Ferraris R; Di Noto C
    Minerva Med; 1984 Feb; 75(8):385-90. PubMed ID: 6709217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of severe infections and septicemia caused by S. aureus (author's transl)].
    Coppens L
    Rev Med Brux; 1982 Jun; 3(6):403-8. PubMed ID: 6921830
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
    Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of inhaled vancomycin hydrochloride on elimination of methicillin-resistant Staphylococcus aureus].
    Shirai M; Ide K; Sato M; Murakami M; Tanaka Y; Sato A; Chida K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1233-9. PubMed ID: 8583715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.
    Kitzis MD; Goldstein FW
    Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin therapy in severe staphylococcal infections.
    Kirby WM
    Rev Infect Dis; 1981; 3 suppl():S236-9. PubMed ID: 7342287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fatal septicemia from Staphylococcus aureus resistance to glycopeptides].
    Villevieille T; Vincenti-Rouquette I; Koeck JL; Petitjeans F; Rousseau JM; Brinquin L
    Ann Fr Anesth Reanim; 2001 May; 20(5):498-9. PubMed ID: 11419246
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacology and efficacy of vancomycin for staphylococcal infections in children.
    Schaad UB; Nelson JD; McCracken GH
    Rev Infect Dis; 1981; 3 suppl():S282-8. PubMed ID: 7342292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations of vancomycin in the management of resistant staphylococcal infections.
    Kollef MH
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S191-5. PubMed ID: 17712746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Aug; 46(33):765-6. PubMed ID: 9272582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
    Giacometti A; Cirioni O; Ghiselli R; Dell'Acqua G; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Rocchi M; Balaban N; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):169-75. PubMed ID: 15629527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jul; 46(27):624-6. PubMed ID: 9218648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B
    Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia.
    Masur H; Francioli P; Ruddy M; Murray HW
    Clin Nephrol; 1983 Aug; 20(2):85-8. PubMed ID: 6616979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
    Madrigal AG; Basuino L; Chambers HF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methicillin resistant Staphylococcus aureus.
    Salaria M; Singh M
    Indian Pediatr; 2001 Jan; 38(1):29-36. PubMed ID: 11175931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.